Financial reports
10-K
2023 FY
Annual report
22 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
29 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
Current reports
8-K
Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
17 Apr 24
8-K
Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
1 Apr 24
8-K
AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results
22 Mar 24
8-K
Material Modifications to Rights of Security Holders
14 Mar 24
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
7 Mar 24
8-K
Entry into a Material Definitive Agreement
14 Feb 24
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
6 Feb 24
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
19 Jan 24
8-K
Departure of Directors or Certain Officers
11 Jan 24
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5 Jan 24
Registration and prospectus
425
Business combination disclosure
7 Mar 24
424B3
Prospectus supplement
14 Feb 24
S-4
Registration of securities issued in business combination transactions
14 Nov 23
425
Business combination disclosure
30 Aug 23
S-8
Registration of securities for employees
6 Feb 23
S-8
Registration of securities for employees
4 Jan 22
425
Business combination disclosure
2 Mar 21
S-3/A
Shelf registration (amended)
26 Jan 21
S-3
Shelf registration
8 Jan 21
Proxies
DEF 14A
Definitive proxy
15 Nov 23
DEFA14A
Additional proxy soliciting materials
7 Nov 23
DEF 14A
Definitive proxy
7 Nov 23
PRE 14A
Preliminary proxy
22 Sep 23
DEFA14A
Additional proxy soliciting materials
2 Nov 22
DEF 14A
Definitive proxy
2 Nov 22
PRER14A
Preliminary revised proxy
5 Oct 22
PRE 14A
Preliminary proxy
16 Sep 22
DEFA14A
Additional proxy soliciting materials
24 Nov 21
DEF 14A
Definitive proxy
24 Nov 21
Other
EFFECT
Notice of effectiveness
14 Feb 24
CORRESP
Correspondence with SEC
13 Feb 24
CORRESP
Correspondence with SEC
6 Feb 24
UPLOAD
Letter from SEC
1 Feb 24
CORRESP
Correspondence with SEC
16 Jan 24
EFFECT
Notice of effectiveness
1 Feb 21
CORRESP
Correspondence with SEC
26 Jan 21
CORRESP
Correspondence with SEC
26 Jan 21
UPLOAD
Letter from SEC
14 Jan 21
CORRESP
Correspondence with SEC
8 Jan 21